Sartorius Stedim buys BioOutsource; Mylan said to invest in Indian facilities;

> Sartorius Stedim Biotech has acquired Scotland-based BioOutsource, which offers contract testing services, including for biosimilars. Release

> Private equity firm Carlyle Group has sold its 11.29% stake in Claris Lifesciences for about $27 million. Report

> Sigma Aldrich ($SIAL) has opened an Asia-Pacific regional headquarters in Singapore. Report

> Mylan ($MYL) will invest in the expansion of its manufacturing facilities in India. Report

And Finally... After finding companies using industrial-grade ingredients in drugs, the Taiwan FDA will create an online system companies will use to record the pharmaceutical raw materials they use. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)